| Browse All

Biofrontera Inc. (BFRIW)

Woburn, United States | NasdaqCM
0.04 USD 0.00 (-6.266%) ⇩ (April 17, 2026, 3:09 p.m. EDT)

Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 9, 2026, 12:23 a.m. EDT

BFRIW exhibits extremely weak fundamentals with a negative profit margin, negative return on assets, and negative return on equity. The stock has been trading near its 52-week low and shows no signs of momentum. Additionally, there are no dividend payouts, and the forecasting model indicates no expected price movement. Given the lack of financial health and stability, this stock is not suitable for either short-term or long-term investment.

None
Attribute Value
Debt to Equity Ratio 58.788
Revenue per Share 4.1
Beta 0.64
Profit Margins -25.26%
Website https://www.biofrontera-us.com

Info Dump

Attribute Value
Address1 660 Main Street
Address2 1st Floor
Ask 0.0
Ask Size 0
Beta 0.644
Bid 0.0
Bid Size 0
Book Value 0.9
City Woburn
Compensation As Of Epoch Date 1,735,603,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.0374
Current Ratio 1.52
Custom Price Alert Confidence HIGH
Day High 0.0399
Day Low 0.0374
Debt To Equity 58.788
Display Name Biofrontera
Ebitda -11,210,000
Ebitda Margins -0.26879
Eps Trailing Twelve Months -1.296
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Two Week High 0.0399
Fifty Two Week High Change -0.0025000013
Fifty Two Week High Change Percent -0.06265667
Fifty Two Week Low 0.0374
Fifty Two Week Low Change 0.0
Fifty Two Week Low Change Percent 0.0
Fifty Two Week Range 0.0374 - 0.0399
Financial Currency USD
First Trade Date Milliseconds 1,772,807,400,000
Float Shares 7,948,233
Free Cashflow -2,362,000
Full Exchange Name NasdaqCM
Full Time Employees 84
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.73710996
Gross Profits 30,741,000
Has Pre Post Market Data 1
Industry
Industry Key
Ipo Expected Date 2,021-10-29
Language en-US
Long Business Summary Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Long Name Biofrontera Inc.
Market us_market
Market State CLOSED
Max Age 86,400
Message Board Id finmb_531568773
Net Income To Common -10,536,000
Open 0.0971
Operating Cashflow -13,361,000
Operating Margins 0.26661
Phone 781 245 1325
Previous Close 0.0399
Price Hint 4
Price To Book 0.041555557
Profit Margins -0.25263
Quick Ratio 1.311
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.0025000013
Regular Market Change Percent -6.265667
Regular Market Day High 0.0399
Regular Market Day Low 0.0374
Regular Market Day Range 0.0374 - 0.0399
Regular Market Open 0.0971
Regular Market Previous Close 0.0399
Regular Market Price 0.0374
Regular Market Time 1,776,452,974
Regular Market Volume 11,405
Return On Assets -0.27998
Return On Equity -1.413
Revenue Growth 0.362
Revenue Per Share 4.1
Sand P52 Week Change 0.38150132
Sector
Sector Key
Short Name Biofrontera Inc. Warrants
Source Interval 15
State MA
Symbol BFRIW
Total Cash 6,401,000
Total Cash Per Share 0.55
Total Debt 6,161,000
Total Revenue 41,705,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.296
Trailing Peg Ratio None
Triggerable 1
Type Disp Equity
Volume 11,405
Website https://www.biofrontera-us.com
Zip 1,801